The Atlanta Criteria represent a vital clinical framework utilized globally to optimize patient selection for transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). Originating from a consensus of experts convened in Atlanta, Georgia, these criteria provide a structured approach to evaluating individuals with severe aortic stenosis who may require intervention. They serve as a dynamic tool to standardize assessment, minimize procedural risk, and ensure that the chosen therapeutic pathway aligns with patient-specific factors, anatomy, and comorbidities.
Historical Context and Development
The evolution of the Atlanta Criteria reflects the rapid advancement in transcatheter valve technology and our understanding of patient risk stratification. Initially developed to define eligibility for early TAVI trials, which were largely restricted to patients deemed inoperable or at high surgical risk, the criteria have undergone significant refinement. As procedural safety has improved and evidence supports TAVI's efficacy in lower-risk populations, the Atlanta Consensus has expanded its scope. This progression underscores a shift from simply identifying who cannot undergo surgery to strategically determining who benefits most from a transcatheter approach versus conventional surgery, incorporating nuanced anatomical and physiological considerations.
Key Patient Selection Parameters
Application of the Atlanta Criteria involves a multidisciplinary team rigorously assessing multiple domains to guide decision-making. The evaluation extends beyond simple risk scores to incorporate anatomical suitability, physiological severity, and individual patient preferences. This comprehensive review ensures that the chosen intervention—whether TAVI or SAVR—offers the optimal balance of efficacy, safety, and long-term outcomes for the specific individual.
Anatomical and Physiological Assessment
Severity of aortic stenosis, typically confirmed by a mean gradient >40 mmHg and/or aortic valve area <1.0 cm².
Assessment of aortic root and annulus dimensions to ensure appropriate valve sizing and compatibility with transcatheter delivery systems.
Evaluation of vascular access feasibility, including the aorta and femoral or alternative peripheral arteries, to accommodate the delivery system.
Systematic review of comorbidities known to influence procedural risk and long-term survival, such as chronic kidney disease, chronic obstructive pulmonary disease (COPD), and prior stroke.
Risk Stratification and the Role of Scores
While the Atlanta Criteria are not a rigid checklist, validated risk scores play a pivotal role within the consensus. The Society of Thoracic Surgeons (STS) Prometric Risk Score is a cornerstone for quantifying surgical mortality risk, providing a benchmark for comparing transcatheter outcomes. Furthermore, the PARTNER paradigms and other clinical trial frameworks often inform the categorization of patients into distinct risk tiers—ranging as low, intermediate, high, or beyond comparison—which directly guide the recommended therapeutic strategy according to the established criteria.
Expanding Indications and Future Directions
The application of the Atlanta Criteria has evolved significantly from its origins in the inoperable population. Current evidence strongly supports TAVI as a preferred option for patients at intermediate and high surgical risk, demonstrating non-inferior or superior outcomes compared to SAVR. Ongoing research continues to refine these guidelines, exploring their utility in younger, lower-risk patients and those with complex anatomies. This continuous reassessment ensures the criteria remain relevant, promoting the delivery of the most appropriate, evidence-based care as the field of structural heart intervention advances.
Clinical Implementation and Multidisciplinary Review
Practical implementation of the Atlanta Criteria hinges on a structured Heart Team approach. This collaborative model, typically comprising interventional cardiologists, cardiac surgeons, imaging specialists, and anesthesiologists, is essential for nuanced interpretation of the criteria. By pooling expertise, the Heart Team can navigate borderline cases, reconcile conflicting data, and arrive at a consensus-driven decision that prioritizes patient welfare. This integrated review process is fundamental to ensuring consistent, high-quality application of the Atlanta Consensus in diverse clinical settings.
